Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Moderna Inc. advanced 5.4% to $143.97 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.0% to 26,333.04 and the Dow Jones Industrial Average rising 1.0% to 52,573.29.

This was the stock's second consecutive day of gains.

Moderna Inc. closed 18.5% short of its 52-week high of $176.66, which the company achieved on August 19th.

The stock outperformed some of its peers, as Johnson & Johnson fell 0.3% to $265.58, Pfizer Inc. rose 0.3% to $27.72, and Gilead Sciences Inc. fell 0.75% to $143.72.

Trading volume totaled 15.3 million, compared to the 50-day average of 17.4 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 11, 2026 16:33 ET (20:33 GMT)